MAXIMIZING ONCOLOGY RESEARCH WITH INTEGRATED KRAS ASSAY SOLUTIONS AND RAS ASSAYS

while in the swiftly evolving subject of oncology investigation, correct and productive mutation screening is important for building specific therapies. The KRAS providers Platform performs a pivotal purpose Within this landscape by featuring thorough remedies for KRAS mutation profiling and Assessment. KRAS mutations, present in somewhere around 9